Status:
ENROLLING_BY_INVITATION
Cognitive Rehabilitation Therapy for COVID-19
Lead Sponsor:
VA Office of Research and Development
Conditions:
Post-Acute COVID-19 Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cognitive dysfunction, psychiatric symptoms, functional impairment, and disability following COVID-19 negatively impact Veterans' community functioning and quality of life, contribute to significant h...
Detailed Description
2-8% of the US population report "long COVID" symptoms - including "brain fog," thinking difficulties, memory problems, and psychiatric symptoms such as sleep disturbance, anxiety, and depression. Rat...
Eligibility Criteria
Inclusion
- Veterans \> 18 years old who are able to provide informed consent
- Prior participation in SF Parent Study or LA Parent Study
- Report of cognitive symptoms that Veteran attributes to COVID-19 infection
Exclusion
- Current substance abuse disorder, psychotic disorder, dementia, etc.
- History of moderate to severe brain injury with loss of consciousness \> 30 minutes
- Auditory or visual impairments that would prevent the ability to participate in assessment procedures
- Invalid performance on one or more embedded performance validity tests (PVTs)
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2029
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06086379
Start Date
July 1 2024
End Date
March 31 2029
Last Update
July 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA San Diego Healthcare System, San Diego, CA
San Diego, California, United States, 92161-0002